Very late relapse of dapsone-induced methaemoglobinemia.
Guillaume
G
Moulis
Haleh
H
Bagheri
Jacques
J
Saint Martory
Pascale
P
Bernard
Jean-Louis
JL
Montastruc
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D003872:Dermatitis / Q000188:drug therapy / Q000378:metabolism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000378:metabolism*; D012008:Recurrence; D013997:Time Factors
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D003622:Dapsone